{"DataElement":{"publicId":"7350732","version":"1","preferredName":"Laboratory Data Domain Specimen Submission Reason","preferredDefinition":"Description of the reason why the specimen/sample was collected.","longName":"SUPPLB_QVAL_LBSPCPURP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7350713","version":"1","preferredName":"Laboratory Data Domain Specimen Submission","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of referring for judgment or consideration by others; the act of handing over something.","longName":"6401816v1.0:2405496v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6401816","version":"1","preferredName":"Laboratory Data Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","longName":"C49592","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Data Domain","conceptCode":"C49592","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7393E896-CD8C-74C0-E053-F662850A1D4C","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2405496","version":"1","preferredName":"Specimen Submitted","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.:Submitted; referred for judgment or consideration.","longName":"C19157:C25695","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Submission","conceptCode":"C25695","definition":"The act of referring for judgment or consideration by others; the act of handing over something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01296C8A-3AC5-1C29-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-20","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-09-20","modifiedBy":"ONEDATA","dateModified":"2005-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA18FB4A-96BB-34E5-E053-4EBD850AB4E7","latestVersionIndicator":"Yes","beginDate":"2020-07-10","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-10","modifiedBy":"SPRINGERL","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7348717","version":"1","preferredName":"Specimen Submission Reason","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._The act of referring for judgment or consideration by others; the act of handing over something._An explanation of the cause of some phenomenon or action.","longName":"7348717v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Allograft rejection or failure","valueDescription":"Allograft Rejection Or Failure","ValueMeaning":{"publicId":"6617845","version":"1","preferredName":"Allograft Rejection Or Failure","longName":"6617845","preferredDefinition":"A graft transferred from a donor of one species to a recipient of the same species but different genetic makeup.: Dismiss from consideration.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A lack of occurrence or performance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allograft","conceptCode":"C60701","definition":"A graft transferred from a donor of one species to a recipient of the same species but different genetic makeup.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reject","conceptCode":"C82650","definition":"Dismiss from consideration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"800CEDAB-52C0-585B-E053-F662850A84A1","latestVersionIndicator":"Yes","beginDate":"2019-01-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-01-22","modifiedBy":"MAESKEB","dateModified":"2019-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-6428-3787-E053-4EBD850A9FF0","beginDate":"2019-01-22","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Central Pathology Review","valueDescription":"Central Pathology Review","ValueMeaning":{"publicId":"4115880","version":"1","preferredName":"Central Pathology Review","longName":"4115880","preferredDefinition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Pathology Review","conceptCode":"C71684","definition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F0F8D0C1-6F65-19E3-E040-BB89AD43427F","latestVersionIndicator":"Yes","beginDate":"2014-01-27","endDate":null,"createdBy":"WONGW","dateCreated":"2014-01-27","modifiedBy":"KUMMEROA","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":"2.23.8.1 Alt VM added per ticket request CADSR0002677. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-643C-3787-E053-4EBD850A9FF0","beginDate":"2014-07-30","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"ctDNA","valueDescription":"ctDNA","ValueMeaning":{"publicId":"5308508","version":"1","preferredName":"ctDNA","longName":"5308508","preferredDefinition":"A metastatic cancer cell found in the peripheral blood.: A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Tumor Cell","conceptCode":"C63797","definition":"A metastatic cancer cell found in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35E2DBF3-61E4-6831-E050-BB89AD436EA6","latestVersionIndicator":"Yes","beginDate":"2016-06-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-06-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-645A-3787-E053-4EBD850A9FF0","beginDate":"2016-06-22","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Diagnosis","valueDescription":"Diagnosis","ValueMeaning":{"publicId":"4434771","version":"1","preferredName":"Diagnosis","longName":"4434771v1.00","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FFD61BEB-3E61-9144-E040-BB89AD43512E","latestVersionIndicator":"Yes","beginDate":"2014-08-04","endDate":null,"createdBy":"WONGW","dateCreated":"2014-08-04","modifiedBy":"ZHWENDY","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/2022: accidentally changed this VM then changed back to what it was.wz","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-646E-3787-E053-4EBD850A9FF0","beginDate":"2018-07-30","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Gene expression","valueDescription":"Gene Expression","ValueMeaning":{"publicId":"2727072","version":"1","preferredName":"Gene Expression","longName":"2727072","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"456C2CE1-2A7F-5A73-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-02-05","endDate":null,"createdBy":"UMLLOADER_CAARRAY","dateCreated":"2008-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-6496-3787-E053-4EBD850A9FF0","beginDate":"2018-11-16","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Eligibility screening","valueDescription":"Trial Screening","ValueMeaning":{"publicId":"4265423","version":"1","preferredName":"Trial Screening","longName":"4265423","preferredDefinition":"A process of active consideration of potential subjects for enrollment in a trial.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trial Screening","conceptCode":"C48262","definition":"A process of active consideration of potential subjects for enrollment in a trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F69E1694-A0D5-E473-E040-BB89AD430F4C","latestVersionIndicator":"Yes","beginDate":"2014-04-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-09","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B8CC27-8B1D-358D-E053-4EBD850AF335","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Banking","valueDescription":"Storage","ValueMeaning":{"publicId":"2673682","version":"1","preferredName":"Storage","longName":"2673682","preferredDefinition":"The act of safekeeping goods in a depository.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Storage","conceptCode":"C60824","definition":"The act of safekeeping goods in a depository.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"382204D4-79B1-01B2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B8CC27-8B31-358D-E053-4EBD850AF335","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"MRD","valueDescription":"Minimal Residual Disease","ValueMeaning":{"publicId":"3664073","version":"1","preferredName":"Minimal Residual Disease","longName":"3664073","preferredDefinition":"remainder of a tumor or a neoplasm/cancer after primary, potentially curative therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurable Residual Disease","conceptCode":"C3896","definition":"Evidence for remaining tumor following primary treatment that is only apparent using highly sensitive techniques.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D44D9BFE-CCF9-ABE8-E040-BB89AD431D2C","latestVersionIndicator":"Yes","beginDate":"2013-01-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-01-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-64DC-3787-E053-4EBD850A9FF0","beginDate":"2015-02-23","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9B6763A-64FA-3787-E053-4EBD850A9FF0","beginDate":"2018-07-30","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"ONEDATA","dateModified":"2020-07-05","deletedIndicator":"No"},{"value":"Central molecular testing","valueDescription":null,"ValueMeaning":{"publicId":"14236581","version":"1","preferredName":"Central Laboratory Molecular Analysis","longName":"14236581v1.00","preferredDefinition":"A laboratory delivering the data for a particular study._A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Laboratory","conceptCode":"C64207","definition":"A laboratory delivering the data for a particular study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"01DDE2DB-5E49-3199-E063-731AD00AEA03","latestVersionIndicator":"Yes","beginDate":"2023-08-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-08-01","modifiedBy":"KUMMEROA","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01DDE2DB-5E4A-3199-E063-731AD00AEA03","beginDate":"2023-08-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-08-01","modifiedBy":"KUMMEROA","dateModified":"2023-08-01","deletedIndicator":"No"},{"value":"GD2 Expression, Generation of Patient-Derived Cell Lines and Xenograft Models","valueDescription":null,"ValueMeaning":{"publicId":"14760949","version":"1","preferredName":"Ganglioside GD2 Protein Expression","longName":"14760949v1.00","preferredDefinition":"A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell lung cancer. GD2, an O-acetylated disialoganglioside, belongs to the group of glycosphingolipids that are widely expressed in many tissues and organs in vertebrates and have been suggested to be involved in the regulation of development and differentiation as recognition molecules or signal modulators. Due to its high level of expression in neuroblastoma, GD2 has the potential to be used as a component of anti-neuroblastoma vaccines, in addition to being used in polyvalent anti-melanoma vaccines._The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ganglioside GD2","conceptCode":"C1110","definition":"A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell lung cancer. GD2, an O-acetylated disialoganglioside, belongs to the group of glycosphingolipids that are widely expressed in many tissues and organs in vertebrates and have been suggested to be involved in the regulation of development and differentiation as recognition molecules or signal modulators. Due to its high level of expression in neuroblastoma, GD2 has the potential to be used as a component of anti-neuroblastoma vaccines, in addition to being used in polyvalent anti-melanoma vaccines.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1170A036-A400-163D-E063-731AD00A3679","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1170A036-A404-163D-E063-731AD00A3679","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Immunogenomic Tumor Profiling","valueDescription":null,"ValueMeaning":{"publicId":"14760950","version":"1","preferredName":"Immunogenicity Study Tumor cDNA Expression Profile","longName":"14760950v1.00","preferredDefinition":"A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject._An analysis of all of the complementary DNA molecules expressed in by a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunogenicity Study","conceptCode":"C120842","definition":"A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor cDNA Expression Profile","conceptCode":"C129771","definition":"An analysis of all of the complementary DNA molecules expressed in by a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1170A036-A401-163D-E063-731AD00A3679","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1170A036-A405-163D-E063-731AD00A3679","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Circulating Tumor Cells to DFCI","valueDescription":null,"ValueMeaning":{"publicId":"14760951","version":"1","preferredName":"Circulating Tumor Cell To Dana Farber Cancer Institute","longName":"14760951v1.00","preferredDefinition":"A metastatic cancer cell found in the peripheral blood._Used as a function word to indicate direction, purpose, or movement._An institute founded in 1947 in Boston, Massachusetts, committed to providing treatment for adults and children with cancer, and developing cures with cutting-edge research.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Tumor Cell","conceptCode":"C63797","definition":"A metastatic cancer cell found in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dana Farber Cancer Institute","conceptCode":"C177330","definition":"An institute founded in 1947 in Boston, Massachusetts, committed to providing treatment for adults and children with cancer, and developing cures with cutting-edge research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1170A036-A402-163D-E063-731AD00A3679","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1170A036-A406-163D-E063-731AD00A3679","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","deletedIndicator":"No"},{"value":"Immune Function Profiling to Emory","valueDescription":null,"ValueMeaning":{"publicId":"14760952","version":"1","preferredName":"Immune Function Testing","longName":"14760952v1.00","preferredDefinition":"The use of a variety of different tests, including blood count and chemistry, urinalysis, and imaging to establish the status of an individual's immune system function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Function Testing","conceptCode":"C116682","definition":"The use of a variety of different tests, including blood count and chemistry, urinalysis, and imaging to establish the status of an individual's immune system function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1170A036-A403-163D-E063-731AD00A3679","latestVersionIndicator":"Yes","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1170A036-A407-163D-E063-731AD00A3679","beginDate":"2024-02-15","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2024-02-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7349860","version":"1","preferredName":"Specimen Submission Reason","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:The act of referring for judgment or consideration by others; the act of handing over something.:An explanation of the cause of some phenomenon or action.","longName":"C19157:C25695:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Submission","conceptCode":"C25695","definition":"The act of referring for judgment or consideration by others; the act of handing over something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9EF59B2-04D7-0CF6-E053-4EBD850A99E9","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9B6763A-6404-3787-E053-4EBD850A9FF0","latestVersionIndicator":"Yes","beginDate":"2020-07-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-05","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":"2023.8.1 PV added per ticket request CADSR0002677. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason why the specimen/sampl","type":"Preferred Question Text","description":"Reason why the specimen/sample was collected:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Specimen purpose:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Specimen purpose","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA17B1E0-592D-2196-E053-4EBD850A7328","latestVersionIndicator":"Yes","beginDate":"2020-07-10","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2020-07-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-01","changeDescription":null,"administrativeNotes":"2023.7.19 AQT added per ticket request CADSR0002626. ak","unresolvedIssues":null,"deletedIndicator":"No"}}